STOCK TITAN
  1. Home
  2. Sec-filings
  3. VOR
  4. [144] Vor Biopharma Inc. SEC Filing

[144] Vor Biopharma Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
144
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock VOR logo
Vor Biopharma Inc.

NASDAQ:VOR

VOR Rankings

#6537 Ranked by Market Cap
N/A Ranked by Dividends
#189 Top Loser

VOR Latest News

Jul 17, 2025
Vor Bio Appoints Qing Zuraw, M.D. as Chief Development Officer
Jul 10, 2025
Vor Bio Appoints Veteran Biotech Executive Sandy Mahatme as Chief Financial Officer and Chief Business Officer
Jul 1, 2025
Vor Bio Report Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Jun 26, 2025
PureTech Founded Entity Vor Bio Announces Exclusive Global License Agreement with RemeGen for Late-Stage Autoimmune Asset and $175 Million Private Placement
Jun 25, 2025
Vor Bio Announces $175 Million Private Placement

VOR Latest SEC Filings

Jul 15, 2025
[144] Vor Biopharma Inc. SEC Filing
Jul 10, 2025
[Form 4] Vor Biopharma Inc. Insider Trading Activity
Jul 10, 2025
[Form 3] Vor Biopharma Inc. Initial Statement of Beneficial Ownership
Jul 10, 2025
[8-K] Vor Biopharma Inc. Reports Material Event
Jul 10, 2025
[144] Vor Biopharma Inc. SEC Filing

VOR Stock Data

317.40M
71.23M
32.03%
49.54%
1.17%
Biotechnology
Biological Products, (no Disgnostic Substances)
Link
United States
CAMBRIDGE